Enovix Corporation (NASDAQ:ENVX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten analysts that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, one has issued a hold rating and seven have issued a buy rating on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $12.6364.
A number of brokerages have recently weighed in on ENVX. JPMorgan Chase & Co. cut shares of Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Wells Fargo & Company set a $6.00 price objective on shares of Enovix in a research note on Thursday, March 12th. TD Cowen reissued a “buy” rating on shares of Enovix in a research note on Thursday. B. Riley Financial dropped their price objective on shares of Enovix from $17.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, March 2nd. Finally, Craig Hallum dropped their price objective on shares of Enovix from $10.00 to $8.00 and set a “buy” rating for the company in a research note on Thursday, May 14th.
Read Our Latest Stock Analysis on Enovix
Institutional Trading of Enovix
Enovix Stock Down 2.9%
ENVX opened at $5.93 on Friday. The business’s fifty day moving average is $5.84 and its two-hundred day moving average is $7.03. The company has a debt-to-equity ratio of 2.14, a quick ratio of 10.65 and a current ratio of 10.97. The company has a market cap of $1.29 billion, a price-to-earnings ratio of -7.14 and a beta of 2.24. Enovix has a one year low of $4.61 and a one year high of $16.49.
Enovix (NASDAQ:ENVX – Get Free Report) last issued its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The business had revenue of $7.60 million during the quarter, compared to analysts’ expectations of $6.95 million. During the same period last year, the company posted ($0.15) EPS. The company’s revenue was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Analysts anticipate that Enovix will post -0.81 EPS for the current fiscal year.
Enovix Company Profile
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
See Also
- Five stocks we like better than Enovix
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
